NCI-EORTC--10th Symposium--new approaches and cellular targets. 16-19 June 1998, Amsterdam, The Netherlands.
This meeting was the tenth in a series dating back 20 years. The symposium provided a forum for the presentation and discussion of recent results on the preclinical and early clinical R and D of new anticancer agents. Reflecting the current opinions in anticancer drug development, there was a much greater emphasis on new biological/molecular-based therapies in comparison to the greater proportion of cytotoxic agents at earlier meetings. Reflecting the current general thinking of new anticancer drug development, a keynote session was dedicated to new approaches and cellular targets. These included telomerase, apoptosis and p53, although in some cases, the targets did not appear particularly new.
Kelland
L
L
CRC Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, UK. lloyd@icr.ac.uk